-
Macroglobulinemia is the
presence of
increased levels of
macroglobulins in the
circulating blood. It is a
plasma cell dyscrasia,
resembling leukemia, with...
- survival, and is
impacted by
polymorphisms in FCGR3A in
Waldenstrom macroglobulinaemia".
British Journal of Haematology. 154 (2): 223–228. doi:10.1111/j...
-
medicinal product Brukinsa,
intended for the
treatment of Waldenström's
macroglobulinaemia. The
applicant for this
medicinal product is
BeiGene Ireland Ltd....
-
chronic lymphocytic leukaemia, non-Hodgkin
lymphoma and
Waldenstrom macroglobulinaemia. Myelosuppression, hyperglycaemia, GI
bleeds (uncommon), pneumonitis...
- (2024). "Review of BCL2
inhibitors for the
treatment of Waldenström's
macroglobulinaemia and non-IgM
lymphoplasmacytic lymphoma".
Frontiers in Oncology. 14:...
-
healthy geriatric patients may have a
monoclonal spike. Waldenström's
macroglobulinaemia (IgM),
monoclonal gammopathy of
undetermined significance (MGUS),...
-
diagnosed with leukaemia, lymphoma, myeloma, MDS, MPN, Waldenström's
macroglobulinaemia,
aplastic anaemia, or amyloidosis. The
Leukaemia Foundation was established...
- cell
carcinoma of the
bladder Uterine leiomyosarcoma Waldenstrom's
macroglobulinaemia Chronic foreign body
reaction Silicone-induced
granulomatous reaction...
-
mantle cell lymphoma, and
lymphoplasmacytic lymphoma (Waldenström's
macroglobulinaemia).
Approval would result in a 10-year
period of
market exclusivity...
- was
granted orphan drug
status for the
treatment of Waldenström's
macroglobulinaemia and
multiple myeloma in 2014.
Ixazomib (trade name Ninlaro) — an orally...
